Literature DB >> 35244887

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis.

Charles T Lee1, Thomas J Galloway2.   

Abstract

OPINION STATEMENT: Oral mucositis (OM) causes significant detriment to patient quality of life. Despite advances in RT, chemotherapy, and surgery for HNC which have led to improved local control and survival, management of certain toxicities such as OM have not kept pace. Numerous strategies have emerged with demonstrable benefit in preventing severe OM. However, ones which are not only effective, but practical and affordable to implement are rare. For example, infusion of growth factors or free radical scavengers, and daily treatment of intra-oral sites with lasers are supported by high-quality evidence but have not become widely adopted. It falls to familiarity of the physician with the available preventative measures and ultimately, patient preference in accepting which strategies for OM amelioration are used. In this review, we present a pathophysiological-based review of prevention techniques available for reducing the incidence and duration of severe OM.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antiseptic; Growth factors; Head and neck cancer; Mouth rinse; Mucositis; Oral; Oral hygiene; Oropharynx; Photobiomodulation; Probiotic; Radiotherapy; Reactive oxygen species; Toxicity

Mesh:

Year:  2022        PMID: 35244887      PMCID: PMC8931694          DOI: 10.1007/s11864-022-00959-z

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  86 in total

Review 1.  The pathobiology of mucositis.

Authors:  Stephen T Sonis
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

2.  Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.

Authors:  Michael Henke; Marc Alfonsi; Paolo Foa; Jordi Giralt; Etienne Bardet; Laura Cerezo; Michaela Salzwimmer; Richard Lizambri; Lara Emmerson; Mon-Gy Chen; Dietmar Berger
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

3.  Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.

Authors:  Noor Al-Dasooqi; Rachel J Gibson; Joanne M Bowen; Richard M Logan; Andrea M Stringer; Dorothy M Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2010-08-03

4.  Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  Yehuda Zadik; Praveen R Arany; Eduardo Rodrigues Fregnani; Paolo Bossi; Héliton Spindola Antunes; René-Jean Bensadoun; Luiz Alcino Gueiros; Alessandra Majorana; Raj G Nair; Vinisha Ranna; Wim J E Tissing; Anusha Vaddi; Rachel Lubart; Cesar Augusto Migliorati; Rajesh V Lalla; Karis Kin Fong Cheng; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

5.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

6.  The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

Authors:  Talha Shaikh; Elizabeth A Handorf; Colin T Murphy; Ranee Mehra; John A Ridge; Thomas J Galloway
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-06       Impact factor: 7.038

7.  A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma.

Authors:  J Bourhis; R De Crevoisier; B Abdulkarim; E Deutsch; A Lusinchi; B Luboinski; P Wibault; F Eschwege
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

8.  Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study.

Authors:  Zhong-He Wang; Shi-Zhou Zhang; Zhi-Yuan Zhang; Chen-Ping Zhang; Hai-Sheng Hu; Wen-Yong Tu; Jessica Kirwan; William M Mendenhall
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

9.  Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study.

Authors:  C Dazzi; A Cariello; P Giovanis; M Monti; B Vertogen; M Leoni; A Tienghi; D Turci; G Rosti; O Nanni; C Rondoni; M Marangolo
Journal:  Ann Oncol       Date:  2003-04       Impact factor: 32.976

Review 10.  Emerging evidence on the pathobiology of mucositis.

Authors:  Noor Al-Dasooqi; Stephen T Sonis; Joanne M Bowen; Emma Bateman; Nicole Blijlevens; Rachel J Gibson; Richard M Logan; Raj G Nair; Andrea M Stringer; Roger Yazbeck; Sharon Elad; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.